Partik Singh, BA, Jonathan I. Silverberg, MD, MPH, PhD

Slides:

Advertisements

Similar presentations

Surgical margins for melanoma in situ

Advertisements

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment Juul M.P.A.

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Analysis of US dermatology physician assistant density

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis Juan Escalas, PhD, MD, Nicole Knöpfel, MD, Ana Martin-Santiago,

Analysis of US dermatology physician assistant density

A girl with a solitary red bulla

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Psoriasis is associated with lipid abnormalities at the onset of skin disease Lotus Mallbris, MD, PhD, Fredrik Granath, PhD, Anders Hamsten, MD, PhD,

Psoriasis: Latitude does make a difference

Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs Joseph F. Fowler, MD, Arindam Ghosh,

Psoriasis and suicidality: A systematic review and meta-analysis

Baldness reversed by chemotherapy

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD

CME examination Journal of the American Academy of Dermatology

Expression of PD-L1 in mastocytosis

Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A review Nolan J. Maloney, BS, Lisa D. Hisaw,

Sarah Sung, MD, Alexa B. Kimball, MD, MPH

Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002 Irwin B. Horwitz, PhD, Brian P. McCall,

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment Juul M.P.A.

JAK inhibitors in dermatology: The promise of a new drug class

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Parul Kathuria, BA, Kenneth B. Gordon, MD, Jonathan I

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

Pilot study of a skin cancer education curriculum for medical students

Applying for dermatology residency is difficult and expensive

Kishore L. Jayakumar, BS, Sara S. Samimi, MD

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Seasonal variation of acne and psoriasis: A 3-year study using the Physician Global Assessment severity scale Vanessa Lindsay Pascoe, MD, Alexandra Boer.

Google search trends for tanning salons: Temporal patterns indicate peak interest in mid spring Derek D. Reed, PhD, BCBA-D Journal of the American Academy.

Vitamin D deficiency in patients with chronic and acute urticaria: A systematic review and meta-analysis Tsung-Yu Tsai, MD, Yu-Chen Huang, MD Journal.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Socioeconomic and geographic barriers to dermatology care in urban and rural US populations Toral Vaidya, MPH, Lindsey Zubritsky, MD, Ali Alikhan, MD,

Infectious rash after riding elephants

Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period

Robert Kantor, BS, Prarthana Dalal, BS, David Cella, PhD, Jonathan I

Lip edema Journal of the American Academy of Dermatology

Jonathan I. Silverberg, MD, PhD, MPH, Nanette B. Silverberg, MD

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD JAAD Case Reports

Pooja H. Rambhia, BA, Ivan J. Stojanov, DMD, Joshua Arbesman, MD

Medicaid acceptance among pediatric dermatologists

Increased risks of autoimmune rheumatic diseases in patients with psoriasis: A nationwide population-based study Hyun Jeong Ju, MD, Ki-Jo Kim, MD, PhD,

Vivek Singam, BLA, Kevin R. Patel, BS, Harrison H

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Derek Y. Hsu, BA, Kenneth Gordon, MD, Jonathan I

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Minimal improvements in the global burden of skin disease from 1990 to 2013 Jessica Mounessa, Taylor Braunberger, MD, Cory A. Dunnick, MD, Robert P. Dellavalle,

Etanercept therapy in two patients with psoriasis and concomitant hepatitis C Clara De Simone, MD, Andrea Paradisi, MD, Rodolfo Capizzi, MD, Angelo Carbone,

Lip ulceration in an immunocompromised patient

A new oral anticoagulant in the setting of dermatologic surgery

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real- world setting: Results from a large, prospective, observational.

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Lisa A. Beck, MD, Sarbjit Saini, MD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Anastasia O. Kurta, DO, Daisy Dai, PhD, Eric S

Presentation transcript:

Growth in the cost of biologics in Medicare beneficiaries, 2013 to 2016 Partik Singh, BA, Jonathan I. Silverberg, MD, MPH, PhD Journal of the American Academy of Dermatology Volume 80, Issue 1, Pages 281-282 (January 2019) DOI: 10.1016/j.jaad.2018.08.004 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Trends in cost per day of biologic medication. Mean cost per day of medication per provider (95% confidence intervals) are plotted by calendar year for biologics approved for psoriasis (solid line) or only other indications (dashed line). All costs are corrected for inflation with reporting in terms of 2016 US dollars. Annualized growth of expenditure per day of medication for adalimumab, etanercept, infliximab, ustekinumab, rituximab, abatacept, and omalizumab were 18.1%, 17.2%, 16.5%, 3.8%, 2.3%, 12.8%, and 5.5%, respectively. Journal of the American Academy of Dermatology 2019 80, 281-282DOI: (10.1016/j.jaad.2018.08.004) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions